Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact

Breaking Down Silos. Connecting Expertise. Accelerating Patient Impact.

Multi-Omics Development & Applications at Precision Medicine Europe

30 November - 01 December 2027
Congress Centre Basel, Basel, Switzerland

The Multi-Omics Development & Applications programme covers how genomic, proteomic and wider multi-omics data is generated and used in drug discovery and development. It is for multi-omics teams, spatial biology experts, translational scientists and technology providers.

Session Themes

Innovations in Spatial Multi-Omics
New spatial technologies and methods for combining molecular data with tissue architecture to reveal cellular interactions and disease mechanisms.

Multi-Omics Applications in Drug Discovery, Translational Development & the Clinic
Using integrated omics data to speed discovery, strengthen translational research, validate biomarkers and support clinical decisions.

Integrated Spatial Biology & Single Cell Analysis
Combining spatial and single-cell methods to map tissue microenvironments, cellular diversity and cell-to-cell interactions.

Featured Sessions

Mapping the Path to Clinical Implementation of Multi-Omics · Achieving Integrated Single Cell & Spatial Analysis Studies · Implementing Alternative Models in Spatial Research (panel)

Multi-omics in Basel

Building on Europe's heritage of biomedical research and scientific collaboration, Multi-Omics at Precision Medicine Europe brings academic institutions, clinical researchers, biotech innovators and pharmaceutical experts together to explore how integrated molecular profiling is advancing precision medicine. With a focus on translational research, cross-border collaboration and clinical validation, the programme showcases the strengths of Europe's multi-omics community.

Basel Skyline

What's changed this year

In 2026, three capabilities converged in multi-omics: higher-resolution biology, including 3D molecular profiling; better integration, with AI connecting molecular layers, imaging and clinical data; and a stronger push towards the clinic. The challenge now is proving clinical utility by showing multi-omics approaches can reliably inform clinical decisions.

Who should attend

Omics Team

Translational Scientists

Bioinformaticians 

Spatial biology specialists  

Single-cell experts 

Clinical genomics teams 

Genomic biomarker researchers 

Proteomics specialists 

Technology providers 

Event Attendee Walking Happily

Featured Speakers from Multi-Omics in Single Cell & Spatial Analysis 2026

Adam Cribbs
Co-Founder & Chief Technology Officer,
Entelo Bio
Amos Lee
Co-Founder & Chief Executive Officer,
Meteor Biotech
ANGELA VASATURO
VP scientific affairs,
Revolune
Anne Marieke Ezendam
Co-Founder & Chief Executive Officer,
SigniGene
Arianna Sabò
Head of Research & Discovery,
Quantro Therapeutics
Calum MacAulay
Clinical Associate Professor, Department of Pathology and Laboratory Medicine,
BC Cancer Research Institute
Chris Mahony
Assistant Professor,
University of Glasgow
Daeseung Lee
Chief Executive Officer and Founder,
Portrai.io
Dirk Paul
Head of Development,
Genomics
Dylan Mooijman
Chief Technology Officer,
Single Cell Discoveries
Edward Oakeley
Chief Technology Officer / Executive Director, AI & Data Science,
Oakeley Ideas
Eugenie Suter
Founding Partner,
European BrainTech Fund
Show More Speakers
Hide Speakers
Günter Schmidt
Vice President, Image Data Sciences,
AstraZeneca
Jens Habermann
Director General of the Biobanking and Biomolecular Resources Research Infrastructure,
European Research Infrastructure Consortium
Joachim Schmid
Vice President, Multiomics Data Solutions,
Illumina
Joanne Yarker
Principal Scientist,
Quotient Therapeutics
Jörg Bachmann
Research Engineer,
SciLifeLab
Julia Foreman
DECIPHER Project Leader,
EMBL - EBI
Kelly Hunter
CSO,
Propath UK
Ken Chow
Health Tech Counsel,
Flanders Investment & Trade
Khalid Saad Khabar Alqurashi
Principal Scientist,
King Faisal Specialist Hospital and Research Centre
Kristin Hellman
Global Product Manager,
Olink, part of Thermo Fisher Scientific
Manfred Claassen
Chief Technology Officer ,
Vicinitybio
Marcus Rauchensteiner
Senior Field Application Scientist,
Twist Bioscience
Maria Teresa Pérez Zaballos
Chief Executive Officer & Founder,
Endogene
Marisa Vanheusden
Senior Scientist,
Muna Therapeutics
Matthew Jackson-Wood
Principal Scientist,
Gilead
Muhammad Aslam
Consultant Pathologist,
Betsi Cadwaladr University Health Board
Muhammed Erkan Karabekmez
Associate Professor,
Istanbul Medeniyet University
Naveed Ishaque
Group Leader,
Charite University Hospital
Olivia Nonn
Senior Researcher ,
Charite University Hospital
Olli Dufva
EMBO/MSCA Postdoctoral Fellow, Teichmann Lab, University of Cambridge,
Wellcome Sanger Institute
Özgün Gökce
Professor,
University of Munich
Patrick Descombes
Senior Expert Genomics,
Société des Produits Nestlé SA Nestlé Research Switzerland
Philip Zimmermann
Chief Executive Officer,
Prevision Medicine AG
Pierre Farmer
Associate Director, Precision Medicine,
Novartis
Pieter Mestdagh
Scientific Business Lead Genomics,
CellCarta
Sathya Muralidhar
Strategic Account Executive,
Aspect Analytics NV
Sherry Derakhshani
Global Product Marketing & Applications Manager – Biopharma Solutions,
ZEISS Life Sciences Solutions
Sinéad Connolly
Life Science Application Scientist,
Cytosurge
Sven Nahnsen
Professor of Biomedical Data Science ,
University of Tuebingen
Tania Vu
Associate Professor,
Oregon Health and Science University
Tarja Laitinen
Senior Specialist,
University of Helsinki
Theodora Stewart
Associate Director Innovation & Business Development,
King's College London
Tushar Shah
Business Development Consultant,
N6
Xingqi Chen
Associate Professor,
Uppsala University

2027 Programme by numbers

17+

Speakers

21+

Sessions

24+

Hours of content

How it connects

AI, Data & Analysis focuses on the technologies, infrastructure and machine learning approaches that turn complex healthcare and biological data into insight, including generative AI, predictive analytics and data integration. The other three programmes show how that insight is used, in biomarkers, pathology and multi-omics. Links to each programme, plus the AI & Data Zone.

Frequently Asked Questions

How do we turn spatial and multi-omics data into clinical decisions?
Two dedicated tracks, Innovations in Spatial Multi-Omics and Multi-Omics Applications in Drug Discovery, Translational Development & the Clinic, cover multi-platform integration, AI-driven analytics, target validation and biomarker development. The discussion Mapping the Path to Clinical Implementation of Multi-Omics looks at what it takes to bridge discovery and the clinic.
What are the newest applications of spatial technology?
Sessions cover subcellular spatial resolution, spatial single-cell interactomics, multimodal barcoding and tissue atlas projects, and how these approaches are revealing cellular interactions and disease biology. They also look at applications in target discovery and therapeutic development, and the practicalities of scaling them.
Where is the value in integrated single-cell and spatial analysis?
Together, single-cell profiling, spatial biology, imaging and multi-omics data give a fuller picture of how cells behave in complex tissue, revealing insights single methods can miss. The Integrated Spatial Biology & Single Cell Analysis track covers patient stratification, immune regulation and target discovery.
How can multi-omics become a core part of pharma R&D?

By moving from one-off studies to scalable, integrated workflows. Sessions cover scaling spatial technologies, tools for spatial samples, integrating platforms, and combining AI with organoid and foundation models, plus how spatial, single-cell and omics data can feed target validation and biomarker development.

When and where is the Multi-omics programme at Precision Medicine Europe?

30 November to 1 December 2027, at Congress Centre Basel. Session times will be on the agenda.

Be part of the conversations shaping
the future of medicine.

30 November - 01 December 2027
Congress Centre Basel, Basel, Switzerland

Spatial Multi-Omics 2026 Agenda at a Glance

DAY ONE 

Track 2: Emerging Multi-Omics Platforms and Applications: Genomics & Transcriptomics 
Track 3: Spatial Biology for Therapeutic Discovery & Development (Oncology & Immunology) 

DAY TWO 

Track 1: Emerging Multi-Omics Platforms and Applications: Proteomics, Epigenomics & Metabolomics 
Track 2: Spatial Biology for Therapeutic Discovery & Development
NGOUS Conference Brochure

Decision 1

Sentence describing Decision 1

Decision 2

Sentence describing Decision 2